Sclerotherapy for lymphatic malformations in children: A scoping review

Journal of Pediatric Surgery

Volumn 46, Issue 5, 2011, Pages 912-922

  Churchill, Paige ^a,b   Otal, Damanjot ^a,c   Pemberton, Julia ^a,c   Ali, Abdullah ^a,b   Flageole, Helene ^a,b,c   Walton, J Mark ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER CHILDREN S HOSPITAL   (Canada)

^c McMaster Pediatric Surgery Research Collaborative   (Canada)

Author keywords

Lymphatic malformations; Pediatric; Sclerotherapy; Scoping review

Indexed keywords

ACETIC ACID; BLEOMYCIN; DOXYCYCLINE; ETHIBLOC; FIBRIN GLUE; LIDOCAINE; PICIBANIL; POLIDOCANOL; TETRACYCLINE;

AIRWAY OBSTRUCTION; APPLICATION SITE DISCHARGE; APPLICATION SITE PAIN; CELLULITIS; CINAHL; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; DRUG ERUPTION; DRUG FEVER; EMBASE; FISTULA; FOLLOW UP; GRANULOMA; HUMAN; INFECTION; INFLAMMATION; LYMPHATIC MALFORMATION; LYMPHATIC SYSTEM DISEASE; MEDLINE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCLEROTHERAPY; SKIN ULCER; SWELLING;

ADOLESCENT; ADULT; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; DIATRIZOATE; DRUG COMBINATIONS; EVIDENCE-BASED MEDICINE; FATTY ACIDS; FEMALE; HUMANS; INFANT; LYMPHATIC ABNORMALITIES; MALE; MIDDLE AGED; PICIBANIL; PROPYLENE GLYCOLS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TREATMENT OUTCOME; YOUNG ADULT; ZEIN;

EID: 79957549964     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2011.02.027     Document Type: Conference Paper

References (62)

1. Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 2008;138:418-24. (Pubitemid 351400253)
2. Greinwald Jr J, Cohen AP, Hemanackah S, et al. Massive lymphatic malformations of the head, neck, and chest. J Otolaryngol Head Neck Surg 2008;37:169-73.
3. Sanlialp I, Karnak I, Tanyel FC, et al. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 2003;67:795-800. (Pubitemid 36677546)
4. Giguere CM, Bauman NM, Smith RJ. New treatment options for lymphangioma in infants and children. Ann Otol Rhinol Laryngol 2002;111:1066-75. (Pubitemid 36020179)
5. Raveh E, de Jong AL, Taylor GP, et al. Prognostic factors in the treatment of lymphatic malformations. Arch Otolaryngol Head Neck Surg 1997;123:1061-5. (Pubitemid 27491927)
6. Lei ZM, Huang XX, Sun ZJ, et al. Surgery of lymphatic malformations in oral and cervicofacial regions in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:338-44.
7. Suzuki Y, Obana A, Gohto Y, et al. Management of orbital lymphangioma using intralesional injection of OK-432. Br J Ophthalmol 2000;84:614-7. (Pubitemid 30339313)
8. Burrows PE, Mitri RK, Alomari A, et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 2008;6:209-16.
9. Smith RJ, Burke DK, Sato Y, et al. OK-432 therapy for lymphangiomas. Arch Otolaryngol Head Neck Surg 1996;122:1195-9. (Pubitemid 26374846)
10. Molitch HI, Unger EC, Witte CL, et al. Percutaneous sclerotherapy of lymphangiomas. Radiology 1995;194:343-7.
11. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005;8:19-32. (Pubitemid 40322704)
12. Howick J, Phillips B, Ball C, et al. Oxford Centre for Evidence-based Medicine - Levels of Evidence. www.cemb.net (Accessed July 4 2010).
13. Emran MA, Dubois J, Laberge L, et al. Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children. J Pediatr Surg 2006;41:975-9.
14. Al-Salem AH. Lymphangiomas in infancy and childhood. Saudi Med J 2004;25:466-9. (Pubitemid 38578549)
15. Baskin D, Tander B, Bankaoglu M. Local bleomycin injection in the treatment of lymphangioma. Eur J Pediatr Surg 2005;15:383-6. (Pubitemid 43067202)
16. Baskota DK, Singh BB, Sinha BK. OK-432: an effective sclerosing agent for the treatment of lymphangiomas of head and neck. Kathmandu Univ Med J (KUMJ) 2007;5:312-7. (Pubitemid 351500348)
17. BaudAV, Breton P, Guibaud L, et al. Treatment of low-pressure vascular malformations by injection of Ethibloc. Study of 19 cases and analysis of complications. Rev Stomatol Chir Maxillofac 2000;101:181-8.
18. Blaszczynski M, Brazert K, Pietryga M, et al. Lymphangioma - the care and treatment in neonates and babies - part two. Ginekol Pol 2004;75:431-8.
19. Dubois J, Garel L, Abela A, et al. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997;204:651-4. (Pubitemid 27369021)
20. Eivazi B, Ardelean M, Baumler W, et al. Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 2009;266:187-97.
21. Emery PJ, Bailey CM, Evans JN. Cystic hygroma of the head and neck. A review of 37 cases. J Laryngol Otol 1984;98:613-9. (Pubitemid 14079021)
22. Giguere CM, Bauman NM, Sato Y, et al. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg 2002;128:1137-44. (Pubitemid 35168103)
23. Greinwald Jr JH, Burke DK, Sato Y, et al. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg 1999;121:381-7. (Pubitemid 29471387)
24. Guvenc BH, Ekingen G, Tuzlaci A, et al. Diffuse neonatal abdominal lymphangiomatosis: management by limited surgical excision and sclerotherapy. Pediatr Surg Int 2005;21:595-8. (Pubitemid 41355606)
25. Herbreteau D, Riche MC, Enjolras O, et al. Percutaneous embolization with Ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients. Int Angiol 1993;12:34-9. (Pubitemid 23217558)
26. Jain R, Bandhu S, Sawhney S, et al. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 2002;30:416-23. (Pubitemid 34970947)
27. Laranne J, Keski-Nisula L, Rautio R, et al. OK-432 (Picibanil) therapy for lymphangiomas in children. Eur Arch Otorhinolaryngol 2002;259:274-8. (Pubitemid 34591726)
28. Luzzatto C, Midrio P, Tchaprassian Z, et al. Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 2000;82:316-8. (Pubitemid 30305650)
29. Mathur NN, Rana I, Bothra R, et al. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol 2005;69:75-80. (Pubitemid 41583094)
30. Ogita S, Tsuto T, Tokiwa K, et al. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987;74:690-1. (Pubitemid 17108421)
31. Okazaki T, Iwatani S, Yanai T, et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg 2007;42:386-9. (Pubitemid 46161564)
32. Orford J, Barker A, Thonell S, et al. Bleomycin therapy for cystic hygroma. J Pediatr Surg 1995;30:1282-7. (Pubitemid 26063482)
33. Puig S, Aref H, Brunelle F. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications. AJR Am J Roentgenol 2003;180:1399-401. (Pubitemid 36504634)
34. Rautio R, Keski-Nisula L, Laranne J, et al. Treatment of lymphangiomas with OK-432 (Picibanil). Cardiovasc Intervent Radiol 2003;26:31-6. (Pubitemid 36919570)
35. Roelly P, Garabedian EN, Attal P, et al. Therapeutic strategy for cervicofacial lymphangioma in children. Ann Otolaryngol Chir Cervicofac 1991;108:227-30.
36. Roelly P, Roger G, Tashjian G, et al. Current therapeutic approach to cervicofacial lymphangiomas in children. Ann Pediatr (Paris) 1992;39:491-4.
37. Schmidt B, Schimpl G, Hollwarth ME. OK-432 therapy of lymphangiomas in children. Eur J Pediatr 1996;155:649-52. (Pubitemid 26232575)
38. Shankar KR, Roche CJ, Carty HM, et al. Cystic retroperitoneal lymphangioma: treatment by image-guided percutaneous catheter drainage and sclerotherapy. Eur Radiol 2001;11:1021-3. (Pubitemid 32755568)
39. Sichel JY, Udassin R, Gozal D, et al. OK-432 therapy for cervical lymphangioma. Laryngoscope 2004;114:1805-9. (Pubitemid 39332259)
40. Uchida K, Inoue M, Araki T, et al. Huge scrotal, flank, and retroperitoneal lymphangioma successfully treated by OK-432 sclerotherapy. Urology 2002;60:1112.
41. Won JH, Kim BM, Kim CH, et al. Percutaneous sclerotherapy of lymphangiomas with acetic acid. J Vasc Interv Radiol 2004;15:595-600. (Pubitemid 38758445)
42. Yoo JC, Ahn Y, Lim YS, et al. OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result. Otolaryngol Head Neck Surg 2009;140:120-3.
43. Zulfiqar MA, Zaleha AM, Zakaria Z, et al. The treatment of neck lymphangioma with intralesional injection of bleomycin. Med J Malaysia 1999;54:478-81.
44. Brewis C, Pracy JP, Albert DM. Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (Picinabil). Clin Otolaryngol 1999;25:130-4. (Pubitemid 30216126)
45. Castanon M, Margarit J, Carrasco R, et al. Long-term follow-up of nineteen cystic lymphangiomas treated with fibrin sealant. J Pediatr Surg 1999;34:1276-9. (Pubitemid 29383575)
46. Sung MW, Chang SO, Choi JH, et al. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. Am J Otolaryngol 1995;16:236-41.
47. Kim KH, Sung MW, Roh JL, et al. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg 2004;131:307-16. (Pubitemid 39208711)
48. Sung MW, Lee DW, Kim DY, et al. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 2001;111:1430-3.
49. Peters DA, Courtemanche DJ, Heran MK, et al. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy. Plast Reconstr Surg 2006;118:1441-6. (Pubitemid 44610395)
50. Claesson G, Kuylenstierna R. OK-432 therapy for lymphatic malformation in 32 patients (28 children). Int J Pediatr Otorhinolaryngol 2002;65:1-6. (Pubitemid 34786329)
51. Ogita S, Tsuto T, Deguchi E, et al. OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg 1991;26:263-8 [discussion 268-70].
52. Charabi B, Bretlau P, Bille M, et al. Cystic hygroma of the head and neck - a long-term follow-up of 44 cases. Acta Otolaryngol Suppl 2000;543:248-50. (Pubitemid 34098637)
53. Ogita S, Tsuto T, Nakamura K, et al. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 1994;29:784-5. (Pubitemid 24191364)
54. Ogita S, Tsuto T, Nakamura K, et al. OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg 1996;31:477-80.
55. Esteban MJ, Gutierrez C, Gomez J, et al. Treatment with Ethibloc of lymphangiomas and venous angiomas. Cir Pediatr 1996;9:158-62.
56. Fernandez Perez J, Moran Penco JM, Pimentel JJ, et al. Retroperitoneal cystic lymphangioma in childhood. Cir Pediatr 2001;14:41-3.
57. Pia F, Aluffi P, Olina M. Cystic lymphangioma in the head and neck region. Acta Otorhinolaryngol Ital 1999;19:87-90.
58. Steiner Z, Pressman A, Mogilner J. Combined sclerotherapy and surgery for huge cervical lymphangioma. Harefuah 1999; 136:779-781, 843, 842.
59. Tovi M, Herbreteau D, Enjolras O, et al. 52 patients with cystic lymphatic vascular malformations. Percutaneous sclerotherapy-simple, fast and repeatable. Lakartidningen 1998;95:643-7. (Pubitemid 128645762)
60. Werner JA, Eivazi B, Folz BJ, et al. State of the art of classification, diagnostics and therapy for cervicofacial hemangiomas and vascular malformations. Laryngorhinootologie 2006;85:883-91. (Pubitemid 46031214)
61. Nakajo T, Saeki M, Ogata T, et al. Cystic lymphangioma-treatments based on analysis of 273 cases. Japn J Pediatr Surg 1984;16:931-8.
62. Adamson IY, Bowden DH. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 1974;77:185-97.